This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Mentor Capital On High Growth Path With Planned $32 Million Health Care IT Investment

Mentor Capital, Inc. (OTC Markets: MNTR) has entered into a $32 million letter of intent with a rapidly growing Health Care I.T. company currently servicing medical practices in over 20 states. Upon execution, the acquisition of $32 million of the Health Care I.T. company shares will increase Mentor Capital cancer and medical assets 330% to $42 million. Mentor has approximately 3 million shares outstanding. Although that implies $14 in medical and cancer assets per share, Mentor notes that at current prices, after allowing for the warrant exercise dilution afforded by financing the purchase, the medical assets may calculate to approximately $3 per common share.

Until the complete funding contract is negotiated, the parties have agreed not to identify their partners. In a letter to shareholders describing the investment, Mentor Capital CEO Chester Billingsley writes, “We are very positive about the growth and multiple acquisition prospects for this company in the Health Care I.T. sector. I am also impressed with the quality of their management team that has the unique hallmarks of entrepreneurial success.” After contract approval Mentor intends to hold a conference call to introduce this important new financial association.

Overall, this third investment would continue the trend of a 4,000% increase in company holdings from $1 million to $42 million in four months. It also keeps Mentor Capital on track to meet the stated management goal of acquiring an average of $10 million in medical or cancer related assets per month, which would fully allocate Mentor’s $125 million in warrant proceeds by year-end.

With some candor, Billingsley comments, “We often mention and are most proud of our socially responsible investing to develop a possible cancer cure and reduce the cost of health care. However, looking toward $42 million in assets and trailing earnings per share of $0.17, versus a recent closing bid price of $0.14 per share that implies the value for all of Mentor is $450,000, perhaps ‘undiscovered high-growth company’ may be the most important description of us.”

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,817.90 +7.84 0.04%
S&P 500 2,069.41 +5.91 0.29%
NASDAQ 4,754.8920 +41.9220 0.89%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs